Ophthalmology, Retina Specialist · Inglewood, CA
NPI
1497836423
Since 2006
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
431 N Prairie Ave
Inglewood, CA, 90301
Phone (310) 671-7172
Groups this clinician bills Medicare through
Medicare paid, 2024
$396K
5,806 services
Medicare patients, 2024
980
Average age 73
Drug cost, 2024
$1.1M
7,824 prescriptions
Company payments, 2025
$16K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James H Peace II was code 92012 (ophthalmological e&m), 1,312 times for 725 patients. In total James H Peace II billed 5,806 services in 36 codes, and Medicare paid $396K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 1,312 | 725 | $67.21 | $88K |
| 92250 Angiography | Office | 893 | 709 | $27.28 | $24K |
| 92014 Ophthalmological E&M | Office | 601 | 432 | $94.92 | $57K |
| 92134 Computerized Ophthalmic Imaging | Office | 417 | 224 | $30.50 | $13K |
| 92235 Angiography | Office | 406 | 351 | $131.94 | $54K |
| 67028 Intravitreal Injection | Office | 293 | 83 | $86.78 | $25K |
| J7999 Compounded drug, not otherwise classified | Office | 284 | 82 | $73.44 | $21K |
| 92083 Vision, Hearing, and Speech Services | Office | 225 | 207 | $47.20 | $11K |
| 83861 Clinical Chemistry | Office | 218 | 107 | $22.03 | $4,803 |
| 92133 Computerized Ophthalmic Imaging | Office | 210 | 196 | $24.22 | $5,087 |
| 92004 Ophthalmological E&M | Office | 162 | 162 | $109.33 | $18K |
| 92020 Ophthalmological E&M | Office | 157 | 148 | $20.50 | $3,218 |
| 95930 Electrical Nerve Conductivity | Office | 138 | 120 | $53.38 | $7,367 |
| 92136 Ultrasound - Nonspecific | Office | 116 | 108 | $35.79 | $4,152 |
| 66984 Cataract Surgery | Facility | 77 | 66 | $421.63 | $32K |
By year: 2022 $657K for 8,394 services; 2023 $550K for 7,365 services; 2024 $396K for 5,806 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 218 | 107 | $22.03 | $4,803 |
Medicare prescription drug claims, 2024
In 2024, the drug James H Peace II prescribed most often to Medicare patients was Latanoprost, with 1,306 prescriptions and refills. In total James H Peace II wrote 7,824 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,306 | 1,811 | 276 | $8,654 |
| Ciprofloxacin Hcl Generic | 928 | 951 | 383 | $11K |
| Lumigan Bimatoprost | 831 | 1,011 | 202 | $259K |
| Brimonidine Tartrate Generic | 638 | 877 | 149 | $28K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 460 | 550 | 119 | $46K |
| Ketorolac Tromethamine Generic | 437 | 576 | 228 | $9,217 |
| Prednisolone Acetate Generic | 384 | 403 | 227 | $10K |
| Timolol Maleate Generic | 371 | 483 | 83 | $2,102 |
| Combigan Brimonidine Tartrate/Timolol | 286 | 338 | 67 | $70K |
| Cyclosporine Generic | 223 | 393 | 91 | $89K |
| Prolensa Bromfenac Sodium | 180 | 208 | 82 | $62K |
| Dorzolamide Hcl Generic | 174 | 283 | 57 | $2,534 |
| Bromfenac Sodium Generic | 169 | 177 | 105 | $38K |
| Restasis Cyclosporine | 151 | 231 | 52 | $135K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 118 | 208 | 43 | $1,802 |
Brand drugs: 4,237 claims; generic drugs: 3,587 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James H Peace II $16K ($16K in general payments such as food, travel and fees) from 9 companies. The largest payer was Bausch & Lomb Americas Inc. with $14K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.